Lanxess (LXS) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
3 Feb, 2026Opening remarks and agenda
Warm welcome to shareholders, with a review of challenging macroeconomic and industry conditions in 2024, including recession and sector-specific headwinds.
Annual Stockholders' Meeting held on May 22, 2025, marking 20 years of operations.
Financial performance review
Operating result increased despite a 5% drop in sales; EBITDA pre-exceptionals rose 20% to EUR 614 million, at the upper end of forecasts.
Cost savings exceeded targets, with over EUR 110 million saved by end of 2023 and permanent reductions of EUR 150 million; further EUR 40 million in cost reductions targeted by end of 2025.
Net financial debt reduced by 5% to EUR 2.4 billion; free cash flow increased by EUR 188 million.
First quarter of 2025 showed a 32% earnings increase; full-year 2025 EBITDA pre-exceptionals forecasted at EUR 600–650 million amid increased macroeconomic uncertainty.
Dividend announcements
Stable dividend of EUR 0.10 per share proposed for 2024, totaling EUR 8.6 million in payouts, emphasizing cost discipline and debt reduction.
Dividend proposal submitted for shareholder approval at the meeting.
Latest events from Lanxess
- Sales and EBITDA dropped, but full-year guidance is confirmed and Q2 is set to improve.LXS
Q1 20267 May 2026 - Sales and EBITDA fell sharply, but full-year guidance is maintained despite ongoing market risks.LXS
Q1 2026 (Media)7 May 2026 - Revenue and earnings declined, but debt reduction and cost cuts support a late 2026 recovery.LXS
Q4 2025 (Media)1 May 2026 - 2026 EBITDA guidance is €450–550 million, with recovery expected in H2 2026.LXS
Q4 202519 Mar 2026 - Q2 2024 EBITDA pre exceptionals surged 69% year-over-year despite lower sales.LXS
Q2 20241 Feb 2026 - EBITDA pre exceptionals jumped 45% and net income returned to profit in Q3 2024.LXS
Q3 202416 Jan 2026 - EBITDA rose 20% in 2024 as cost savings and portfolio focus drove profitability gains.LXS
Q4 202426 Dec 2025 - Q2 sales and EBITDA fell on weak demand, but net debt dropped after Urethane divestment.LXS
Q2 202523 Nov 2025 - EBITDA pre up 32% to €133m; guidance held as Urethane sale supports debt reduction.LXS
Q1 202517 Nov 2025